Watch Ticker

Portage Biotech Inc. Common Stock

Go to Portage Biotech Inc. Common Stock Website

$5.87

0.00 (0.00%)

Live

Previous Close

$5.87

Day Range

$0 - $0

Previous Day Range

$5.35 - $5.87

Market Cap

$12.4 million USD

Day Vol.

Previous Day Vol.

25321

Currency

USD

Primary Exchange

Nasdaq

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements

Portage Biotech, a clinical-stage immuno-oncology company, announced that it has evidenced compliance with all applicable requirements for continued listing on The Nasdaq Capital Market.

Related tickers: PRTG.

Read Full Article

N/A - Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

Portage Biotech reports positive preclinical data for its selective adenosine A2B receptor inhibitor PORT-7 in a murine mesothelioma model, demonstrating superior single-agent activity compared to anti-PD1 antibody and further improvement in combination. The company plans to commence a first-in-human clinical trial with PORT-7.

Related tickers: PRTG.

Read Full Article

Trending Tickers

Please sign in to view